IFIT3 and head and neck squamous cell carcinoma: IFIT3 is highly expressed in HNSCC tissues, and its abnormal overexpression is directly correlated with poor prognosis in patients with clinical stage IV or pathological grade 3, as reflected by significantly reduced survival rates.